Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,704 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

NCT06789224

Conditions
Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +74 more
Locations
  • Kliniken der Stadt Köln gGmbH Cologne, North Rhine-Westphalia, Germany
  • Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätsklinikum Frankfurt Frankfurt, Germany
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik für Anästhesiologie Mainz, Germany
  • Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie Mannheim, Germany
View Trial Details
Completed

LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

NCT01828099

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site La Rioja, Argentina
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
View all 167 locations
View Trial Details
Completed

CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)

NCT03504488

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +24 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope - Duarte Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
View all 59 locations
View Trial Details
Completed

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

NCT04249362

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Tampa, Florida, United States
  • Research Site Royal Oak, Michigan, United States
  • Research Site Limoges, France
View all 35 locations
View Trial Details
Completed

Universal Cancer Peptide-based Vaccination in Metastatic NSCLC

NCT02818426

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Hospitalier Régional Universitaire de Besançon Besançon, France
  • Centre Georges François Leclerc Dijon, France
  • Hôpital Emile Muller Mulhouse, France
  • St Louis Hospital Paris, France
View Trial Details
Completed

Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients

NCT00418886

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Research Site Casa Grande, Arizona, United States
  • Research Site Chandler, Arizona, United States
  • Research Site Farmington, Connecticut, United States
  • Research Site Stamford, Connecticut, United States
View all 110 locations
View Trial Details

Related conditions